Your browser doesn't support javascript.
loading
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer.
Boudadi, Karim; Suzman, Daniel L; Anagnostou, Valsamo; Fu, Wei; Luber, Brandon; Wang, Hao; Niknafs, Noushin; White, James R; Silberstein, John L; Sullivan, Rana; Dowling, Donna; Harb, Rana; Nirschl, Thomas R; Veeneman, Brendan A; Tomlins, Scott A; Wang, Yipeng; Jendrisak, Adam; Graf, Ryon P; Dittamore, Ryan; Carducci, Michael A; Eisenberger, Mario A; Haffner, Michael C; Meeker, Alan K; Eshleman, James R; Luo, Jun; Velculescu, Victor E; Drake, Charles G; Antonarakis, Emmanuel S.
Afiliação
  • Boudadi K; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Suzman DL; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Anagnostou V; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Fu W; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Luber B; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Wang H; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Niknafs N; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • White JR; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Silberstein JL; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Sullivan R; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Dowling D; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Harb R; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Nirschl TR; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Veeneman BA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Tomlins SA; Present address: Pfizer Inc., Pearl River, NY, USA.
  • Wang Y; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Jendrisak A; Department of Urology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Graf RP; Epic Sciences Inc., San Diego, CA, USA.
  • Dittamore R; Epic Sciences Inc., San Diego, CA, USA.
  • Carducci MA; Epic Sciences Inc., San Diego, CA, USA.
  • Eisenberger MA; Epic Sciences Inc., San Diego, CA, USA.
  • Haffner MC; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Meeker AK; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Eshleman JR; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Luo J; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Velculescu VE; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Drake CG; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Antonarakis ES; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Oncotarget ; 9(47): 28561-28571, 2018 Jun 19.
Article em En | MEDLINE | ID: mdl-29983880
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article